Kazia Therapeutics Ltd ADR
KZIA | NASDAQ
$10.92
+$0.27 (+2.54%)
At close: Sep 22, 2026, 4:00 PM ET
$10.73
-$0.19 (-1.77%)
After-hours:
Sep 22, 2026, 7:35 PM ET
Market Data
Market Cap $17.25M
Enterprise Value $-43.44M
Beta 2.15
Average Volume 223.69K
Shares Outstanding (Diluted) 3.12M
Shares Change YoY 550.63%
Institutional Ownership 56.21%
Exchange NASDAQ
ISIN US48669G3039
Price Performance
Price Change 1M -20.3%
Price Change 3M -27.5%
Price Change 6M 45.9%
Price Change YTD 113.0%
Price Change 1Y 41.6%
Price Change 3Y -79.3%
Price Change 5Y -98.1%
1M CAGR (ann.) -23.3%
1Y CAGR (ann.) 37.8%
5Y CAGR (ann.) -54.0%
All-Time CAGR -25.3%
Valuation
PE Ratio -1.59
Forward PE N/A
PEG Ratio -0.02
Forward PEG -0.04
PS Ratio 1,355.89
Forward PS 41.90
PB Ratio 0.56
P/FCF Ratio -2.95
P/Adj. FCF Ratio -2.95
P/OCF Ratio -3.89
EV/Sales -2,204.00
EV/EBIT 2.39
EV/EBITDA 2.39
EV/FCF 4.79
Earnings Yield -69.0%
FCF Yield -37.3%
Adj. FCF Yield -37.3%
Financial Health
Net Cash A$69.29M
Total Debt A$98.71K
Cash & Short-Term Investments A$69.39M
Total Assets A$71.04M
Current Ratio 2.87
Quick Ratio 2.87
Debt / Equity Ratio 0.00
Debt / EBITDA -0.01
Debt / FCF -0.01
OCF / Debt -133.90
Interest Coverage 0.00
Altman Z-Score -2.31
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -92086.4%
EBITDA Margin -92086.4%
Net Profit Margin -113004.6%
FCF Margin -46038.4%
Adj. FCF Margin -46038.4%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -31.4%
Return on Equity -116.9%
Return on Invested Capital -36.2%
Return on Capital Employed -38.9%
Return on Tangible Assets -31.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -75.2%
Revenue CAGR 5Y -63.8%
Revenue CAGR 10Y -48.7%
EPS CAGR 3Y 71.7%
EPS CAGR 5Y 29.5%
EPS CAGR 10Y 36.6%
FCF CAGR 3Y -4.2%
FCF CAGR 5Y -2.7%
FCF CAGR 10Y 1.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 25.1%
Revenue Growth Next 3Y 293.0%
Earnings Date Mar 1, 2027
EPS Estimate (next Q) -$0.32
EPS Growth Est (next Q) -22.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $31.50
Price Target Upside 195.8%
Cash Flow
Operating Cash Flow A$-13.22M
Free Cash Flow A$-9.07M
Adj. Free Cash Flow A$-9.07M
FCF Per Share -$2.91
OCF Per Share -$4.24
OCF/S Ratio -67055.4%
Income Statement
Revenue A$19.71K
Gross Profit A$19.71K
Operating Income A$-18.15M
EBITDA A$-18.15M
Net Income A$-22.27M
EPS (Diluted) -$10.35
Revenue / Employee $3.29K
Profit / Employee $-3.71M
Employees 6
Add to Watchlist
Select watchlists to add or remove KZIA